FilingSEC EDGAR8-K
Silexion Therapeutics Receives Nasdaq Delisting Notice and Plans Appeal
· SEC accepted
Stagelisting
Filing content
Silexion Therapeutics has received a delisting notice from Nasdaq due to non-compliance with the minimum shareholders' equity requirement and intends to request an appeal.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…